César Augusto
Rodríguez Sánchez

Foto de César Augusto

Foto de Instituto Valenciano de Oncologia

Instituto Valenciano de Oncologia

Valencia, España

Publicaciones en colaboración con investigadores/as de Instituto Valenciano de Oncologia (4)

2024

Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management
Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1539-1548

2022

Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
Breast, Vol. 66, pp. 77-84

2020

A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
Breast, Vol. 54, pp. 286-292